• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学上模仿浆细胞瘤的间变性甲状腺癌

Anaplastic Thyroid Carcinoma Histologically Mimicking a Plasmacytoma.

作者信息

Mo Joshua H, Tan Donald, Zhao Xiaohui S, Tjoa Tjoson, Wang Beverly Y

机构信息

Department of Pathology and Laboratory Medicine, UC Irvine School of Medicine, Irvine, CA 92617, USA.

Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, CA 92697, USA.

出版信息

Diagnostics (Basel). 2020 Jan 8;10(1):29. doi: 10.3390/diagnostics10010029.

DOI:10.3390/diagnostics10010029
PMID:31936233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7168172/
Abstract

Anaplastic (undifferentiated) thyroid carcinoma (ATC) is a rare malignancy which may arise from transformation of a pre-existing differentiated carcinoma. We report the unique case where a lesion of thyroid origin presented with the histological features of mature plasma cells. Immunohistochemistry confirmed the lesion to be an anaplastic thyroid carcinoma arising from papillary thyroid carcinoma. A tumor mimicking a malignancy of a different cellular origin can lead clinicians to incorrect treatment approaches. Careful correlation with clinical details and knowledge of these unique presentations is important for reaching the correct diagnosis.

摘要

间变性(未分化)甲状腺癌(ATC)是一种罕见的恶性肿瘤,可能由先前存在的分化型癌转变而来。我们报告了一例独特的病例,甲状腺来源的病变呈现出成熟浆细胞的组织学特征。免疫组化证实该病变是起源于乳头状甲状腺癌的间变性甲状腺癌。一种模仿不同细胞起源恶性肿瘤的肿瘤可能会导致临床医生采取错误的治疗方法。仔细结合临床细节并了解这些独特表现对于做出正确诊断很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7168172/4497d1850581/diagnostics-10-00029-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7168172/96911f495958/diagnostics-10-00029-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7168172/4497d1850581/diagnostics-10-00029-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7168172/96911f495958/diagnostics-10-00029-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1458/7168172/4497d1850581/diagnostics-10-00029-g002.jpg

相似文献

1
Anaplastic Thyroid Carcinoma Histologically Mimicking a Plasmacytoma.组织学上模仿浆细胞瘤的间变性甲状腺癌
Diagnostics (Basel). 2020 Jan 8;10(1):29. doi: 10.3390/diagnostics10010029.
2
Anaplastic transformation of metastatic papillary thyroid carcinoma lesion histologically mimicking a squamous cell carcinoma: A case report.组织学上模拟鳞状细胞癌的转移性乳头状甲状腺癌病变的间变性转化:一例报告。
Int J Surg Case Rep. 2024 Nov;124:110396. doi: 10.1016/j.ijscr.2024.110396. Epub 2024 Sep 30.
3
Intrathyroidal Plasmacytoma with Pleomorphic Multilobated Bizarre Cells: A Rare Primary Clinicopathological Presentation Mimicking Anaplastic Carcinoma of Thyroid.甲状腺内浆细胞瘤伴多叶奇异形态细胞:罕见的原发性临床病理表现,类似于甲状腺间变性癌。
Head Neck Pathol. 2022 Dec;16(4):1257-1262. doi: 10.1007/s12105-022-01465-2. Epub 2022 Jun 14.
4
Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma.在使用乐伐替尼治疗乳头状甲状腺癌后诊断出的间变性甲状腺癌。
Endocrinol Diabetes Metab Case Rep. 2019 Oct 1;2019. doi: 10.1530/EDM-19-0085.
5
Coexistence of Oncocytic (Hürthle cell) carcinoma with foci of anaplastic carcinoma and a metastasizing papillary carcinoma in one thyroid gland: Rare case report.一例甲状腺内嗜酸性(许特莱细胞)癌合并间变性癌灶及转移性乳头状癌共存的罕见病例报告
Int J Surg Case Rep. 2023 May;106:108174. doi: 10.1016/j.ijscr.2023.108174. Epub 2023 Apr 11.
6
Anaplastic thyroid carcinoma with rhabdoid phenotype: An unusual case and a comprehensive review.具有横纹肌样表型的间变性甲状腺癌:一个不寻常的病例及全面复习。
Diagn Cytopathol. 2020 Nov;48(11):1125-1130. doi: 10.1002/dc.24516. Epub 2020 Jun 9.
7
Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.间变性甲状腺癌的罕见表现:BRAF 突变分析的作用。
J Korean Med Sci. 2017 Oct;32(10):1721-1726. doi: 10.3346/jkms.2017.32.10.1721.
8
Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.乳头状和间变性甲状腺癌中改变的生物标志物表达谱:突尼斯患者的贡献
Bull Cancer. 2017 May;104(5):433-441. doi: 10.1016/j.bulcan.2016.12.001. Epub 2017 Feb 6.
9
Anaplastic transformation of differentiated thyroid carcinoma.分化型甲状腺癌的间变转化
Int J Health Sci (Qassim). 2009 Jan;3(1):93-6.
10
[Anaplastic carcinoma of the thyroid].
Arch Anat Cytol Pathol. 1998;46(1-2):87-93.

本文引用的文献

1
Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.索拉非尼治疗日本局部晚期或转移性甲状腺髓样癌和间变性甲状腺癌患者。
Thyroid. 2017 Sep;27(9):1142-1148. doi: 10.1089/thy.2016.0621. Epub 2017 Jul 24.
2
Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy.间变性甲状腺癌:分子靶向治疗时代的治疗方法
J Oncol Pract. 2016 Jun;12(6):511-8. doi: 10.1200/JOP.2016.012013.
3
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
低分化和间变性甲状腺癌的基因组和转录组特征
J Clin Invest. 2016 Mar 1;126(3):1052-66. doi: 10.1172/JCI85271. Epub 2016 Feb 15.
4
Management of anaplastic thyroid cancer.间变性甲状腺癌的管理
Gland Surg. 2015 Feb;4(1):44-51. doi: 10.3978/j.issn.2227-684X.2014.12.02.
5
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.通过全外显子组测序对间变性甲状腺癌的突变图谱进行特征分析。
Hum Mol Genet. 2015 Apr 15;24(8):2318-29. doi: 10.1093/hmg/ddu749. Epub 2015 Jan 9.
6
BRAF V600E inhibition in anaplastic thyroid cancer.BRAF V600E 抑制在间变性甲状腺癌中的作用
N Engl J Med. 2013 Feb 14;368(7):684-5. doi: 10.1056/NEJMc1215697.
7
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.美国甲状腺协会关于治疗间变性甲状腺癌患者的指南。
Thyroid. 2012 Nov;22(11):1104-39. doi: 10.1089/thy.2012.0302.
8
Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.间变性甲状腺癌:流行病学、发病机制和治疗的综述。
J Oncol. 2011;2011:542358. doi: 10.1155/2011/542358. Epub 2011 Jun 12.
9
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy.间变性甲状腺癌:适形放疗的临床结果。
Head Neck. 2010 Jul;32(7):829-36. doi: 10.1002/hed.21257.
10
Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients.间变性甲状腺癌的多模式治疗——75例患者的治疗结果
Radiother Oncol. 2009 Jul;92(1):100-4. doi: 10.1016/j.radonc.2009.02.016. Epub 2009 Mar 26.